The neurobiology of schizophrenia: new leads and avenues for treatment.
about
PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence.Mice lacking collapsin response mediator protein 1 manifest hyperactivity, impaired learning and memory, and impaired prepulse inhibition.Progress in defining the biological causes of schizophrenia.How might ZNF804A variants influence risk for schizophrenia and bipolar disorder? A literature review, synthesis, and bioinformatic analysis.Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries.New Targets for Schizophrenia Treatment beyond the Dopamine HypothesisShort overview on metabolomic approach and redox changes in psychiatric disorders.
P2860
Q28567753-E5AC65E5-3B1A-4BF8-AF70-E7DC48C853A8Q37415519-2AE4B49A-5294-4EC5-99FD-1D6521A8C120Q37906804-A5F6FEB9-7A27-4770-817A-30BF1DE17B85Q38152423-8FC24B2D-0ECE-4CC3-BE0A-D4975E1283C6Q38209914-798A80F8-3CFB-4BDA-B478-D54E7F8AD0FFQ41573540-A4B19650-B32A-4BF7-A7E0-9C60A96DC6EFQ41791000-E95229C8-DDA1-4F52-9D1F-64DC10BEC930
P2860
The neurobiology of schizophrenia: new leads and avenues for treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The neurobiology of schizophrenia: new leads and avenues for treatment.
@en
The neurobiology of schizophrenia: new leads and avenues for treatment.
@nl
type
label
The neurobiology of schizophrenia: new leads and avenues for treatment.
@en
The neurobiology of schizophrenia: new leads and avenues for treatment.
@nl
prefLabel
The neurobiology of schizophrenia: new leads and avenues for treatment.
@en
The neurobiology of schizophrenia: new leads and avenues for treatment.
@nl
P50
P1476
The neurobiology of schizophrenia: new leads and avenues for treatment
@en
P2093
F Markus Leweke
P304
P356
10.1016/J.CONB.2010.09.008
P577
2010-10-08T00:00:00Z